Correct usage and recommended dosage of Trelagliptin

Trelagliptin (Trelagliptin), as a new DPP-4 inhibitor, provides patients with type 2 diabetes with a convenient once-weekly oral treatment regimen. The drug prolongs the half-life of glucagon-like peptide-1 (GLP-1) and pancreatic statin-secreting hormone (GIP) by inhibiting DPP-4 enzyme activity, promotes pancreatic β-cells to secrete insulin after meals, and inhibits gluconeogenesis, thereby effectively controlling postprandial blood sugar fluctuations.

The recommended dose is 100 mg taken orally once a week for adults. It should be taken on the same day every week to ensure stable concentration of the drug in the blood and long-term blood sugar control effect. Patients do not need to consider taking it on an empty stomach or after meals, and drug absorption is not affected by food. This feature significantly improves the convenience and compliance of medication. For patients with mild to moderate renal impairment, there is no need to adjust the dose, but patients with severe renal impairment should use it under the guidance of a doctor to ensure safety.

In actual clinical applications, trotagliptin is often used as an auxiliary drug for diet therapy and exercise therapy, and can also be used in combination with other oral hypoglycemic drugs to achieve more ideal blood sugar control. The once-weekly dosing design not only reduces the risk of patients missing doses, but also reduces the burden of medication management and improves long-term treatment compliance. Patients should regularly monitor blood sugar and renal function during medication, and pay attention to whether gastrointestinal discomfort or other minor adverse reactions occur.

Scientific and reasonable dosage and standardized administration are the keys to the optimal efficacy of trolagliptin. Patients who adhere to the correct usage and dosage for a long time can usually achieve stable blood sugar control while reducing the risk of hypoglycemia, providing a safe, convenient and effective solution for type 2 diabetes management.

Reference materials:https://en.wikipedia.org/wiki/Trelagliptin